Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;7(6):1174-6.
doi: 10.7860/JCDR/2013/5390.3069. Epub 2013 Jun 1.

Dilated cardiomyopathy: an anaesthetic challenge

Affiliations

Dilated cardiomyopathy: an anaesthetic challenge

Haramritpal Kaur et al. J Clin Diagn Res. 2013 Jun.

Abstract

Idiopathic dilated cardiomyopathy is a primary myocardial disease of unknown etiology characterized by left ventricular or biventricular dilation and impaired contractility. Depending upon diagnostic criteria used, the reported annual incidence varies between 5 and 8 cases per 100,000 populations. Dilated cardiomyopathy is defined by presence of: a) fractional myocardial shortening less than 25% (>2SD) and/or ejection fraction less than 45% (>2SD) and b) Left Ventricular End Diastolic Diameter (LVEDD) greater than 117% excluding any known cause of myocardial disease. Such cases are always a challenge to the anesthesiologist as they are most commonly complicated by progressive cardiac failure. We report the anesthetic management of a patient with dilated cardiomyopathy undergoing surgery for carcinoma breast.

Keywords: Anaesthetic management; Dilated cardiomyopathy; Idiopathic.

PubMed Disclaimer

Figures

[Table/Fig-1]:
[Table/Fig-1]:
ECG showing left bundle branch block and poor progression of R wave in lead V1-V5
[Table/Fig-2]:
[Table/Fig-2]:
Chest X-ray Showing dilated cardiomyopathy

References

    1. Stevenson LW, Perloff JK. The Dilated cardiomyopathy: clinical aspects. Cardiol Clin. 1988;6:187–218. - PubMed
    1. Stoelting RK, Dierdorf SF. Anaesthesia and Coexisting Disease. (3rd ed) New York: Churchill Livingstone; 1993. Cardiomyopathy. In: Stoelting RK (Ed) pp. 97–102.
    1. Molhoek SG, Bax JJ, Erven RV. Effectiveness of resynchronization therapy in patients with end stage heart failure. Am J Cardiol. 2002;90:379–83. - PubMed
    1. Schechter WS, Kim C, Martinez M. Anesthetic induction in a child with end-stage cardiomyopathy. Can J Anaesth. 1995;42:404–08. - PubMed
    1. Sharma R, Francis DP, Pitt B. Hemoglobin perdicts survival in patients with chronic heart failure: a sub study of the ELITE II trial. Eur Heart J. 2004;25(12):1021–28. - PubMed

LinkOut - more resources